Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease

Area of Science:

• Rheumatology and Cardiology
• Inflammatory Diseases
• Cardiovascular Health

Background:

• Ankylosing spondylitis (AS) is linked to increased cardiovascular (CV) morbidity compared to the general population.
• The elevated CV risk in AS is attributed to multifactorial causes, including inflammation-driven atherosclerosis and direct cardiac inflammation (aortitis, conduction anomalies).
• Establishing a definitive link is challenging due to AS's rarity (1:1,000) and small study sample sizes limiting long-term outcome data.

Purpose of the Study:

• To review existing literature on the association between ankylosing spondylitis and cardiovascular disease.
• To explore the impact of therapies used for AS on the cardiovascular system.

Main Methods:

• Literature review of studies investigating the AS-CV disease association.
• Analysis of research on the cardiovascular effects of AS treatments.

Main Results:

• Studies indicate a higher prevalence of cardiovascular morbidity in AS patients.
• Inflammation in AS contributes to accelerated atherosclerosis and direct cardiac involvement.
• Data on long-term outcomes and treatment impacts are limited by study sizes.

Conclusions:

• Ankylosing spondylitis is associated with significant cardiovascular risks.
• Further research is needed to fully elucidate the AS-CV disease relationship and treatment effects.